CD46, a complement regulatory protein/measles virus receptor, and its relation to hematological disorders

International Journal of Hematology

Volumn 64, Issue 2, 1996, Pages 101-109

  Seya, Tsukasa ^a,b  

^a JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^b CENTER FOR ADULT DISEASES   (Japan)

Author keywords

Immune suppression; Membrane cofactor protein (MCP, CD46); Regulator of complement activation (RCA); Short consensus repeat (SCR); Virus receptors

Indexed keywords

MEMBRANE COFACTOR PROTEIN; REGULATOR OF COMPLEMENT ACTIVATION; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

COMPLEMENT ACTIVATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEASLES VIRUS; PRIORITY JOURNAL; REVIEW;

EID: 0030219978     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-5710(96)00476-8     Document Type: Review

References (38)

1. [1] von Pirquet, C. Das Verhalten der kutanen Tuberculinreaktion wahrend der Masern. Dtsch Med Wochenschr 1908;30;1297-1300.
2. [2] McChesney MB, Oldstone MBA, Viruses perturb lymphocyte functions: Selected principles characterizing virus-induced immunosuppression. Annu Rev Immunol 1987;5:279-304,
3. [3] Casali P, Nakamura M, McChesney MB. Immunosuppression by measles virus. In: Spector S, Bendinelli M and Friedman H, (eds.). Virus-induced immunosuppression. London/New York: Plenum, 1989;345-373.
4. [4] Yanagi Y, Cubitt BA, Oldstone MBA. Measles virus inhibits mitogen-induced T cell proliferation but does not directly perturb the T cell activation process inside the cell. Virology 1992;187:280-289.
5. [5] McChesney MB, Fujinami RS, Lampert PW, Oldstone MBA. Viruses disrupt functions of human lymphocytes. II. Measles virus suppresses antibody production by acting on B lymphocytes. J Exp Med 1986;163:1331-1336.
6. [6] Sullivan JL, Barry DW, Lucas SJ, Albrecht P. Measles infection of human mononuclear cells. I. Acute infection of peripheral blood lymphocytes and monocytes. J Exp Med 1975;142:773-784.
7. [7] Clerici M, Shearer GM. A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
8. [81 Dorig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993;75:295-305.
9. [9] Naniche D, Varior KG, Cervoni F, Wild TF, Rossi B, Rabourdin CC, Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993;67:6025-6032.
10. [10] Seya T, Turner JR, Atkinson JP. Purification and characterization of a membrane protein (gp 45-70) which is a cofactor for cleavage of C3b and C4b. J Exp Med 1986;163:837-855.
11. [11] Seya T, Atkinson JP. Functional properties of membrane cofactor protein of complement. Biochem J 1989;264: 581-588.
12. [12] Lublin DM, Linzesky MK, Post TW, Arce MA, Le Bearu MM, Rebentisch MB, Lemons RS, Seya T, Atkinson JP. Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP): evidence for inclusion in multi-gene family of complement-regulatory proteins. J Exp Med 1988;168:181-194.
13. [13] Reid KBM, Day AJ. Structure-function relationships of the complement components. Immunol Today 1989;10:177-180.
14. [14] Seya T. Human regulator of complement activation gene family proteins and their relationship to microbial infection. Microbiol Immunol 1995;39:295-305.
15. [15] Seya T, Hara T, Matsumoto M, Akedo H. Quantitative analysis of membrane cofactor protein (MCP) of complement: High expression of MCP on human leukemia cell lines, which is down-regulated during cell-differentiation. J Immunol 1990;145:238-245.
16. [16] Russell SM, Sparrow RL, McKenzie IFC, Purcell DFJ. Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur J Immunol 1992;22:1513-1518.
17. [17] Johnstone RW, Russell SM, Loveland BE, McKenzie IFC. Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing. Mol Immunol 1993;30:1231-1241.
18. [18] Seya T, Hara T, Iwata K, Kuriyama S, Hasegawa T, Nagase Y, Miyagawa S, Matsumoto M, Hatanaka M, Atkinson JP, Nagasawa S. Purification and functional properties of soluble forms of membrane cofactor protein (MCP, CD46) of complement: Identification of forms increased in cancer patients' sera. Int Immunol 1995;7:727-736.
19. [19] Post TW, Liszewski MK, Adams EM, Tedja I, Miller EA, Atkinson JP. Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype. J Exp Med 1991;174:93-102.
20. A domain in CD46 up-regulation. Scand J Immunol 1995;42:581-590.
21. [21] Kojima A, Iwata K, Seya T, Matsumoto M, Ariga H, Atkinson JP, Nagasawa S. Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis. J Immunol 1993;151:1519-1527.
22. [22] Iwata K, Seya T, Ariga H, Nagasawa S. Expression of a hybrid complement regulatory protein, membrane cofactor protein (MCP)-decay-accelerating factor (DAF) on Chinese hamster ovary cells; comparison of its regulatory effect with those of DAF and MCP. J Immunol 1994;152:3436-3444.
23. [23] Lublin DM, Coyne KE. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage. J Exp Med 1991;174:35-44.
24. [24] Seya T, Hara T, Matsumoto M, Sugita Y, Akedo H. Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46). J Exp Med 1990;172:1673-1680.
25. [25] Iwata K, Seya T, Ariga H, Ueda S, Nagasawa S. Modulation of complement regulatory function and measles virus receptor function by the serine-threonine-rich domains of membrane cofactor protein (CD46). Biochem J 1994;304:169-175.
26. [26] Manchester M, Liszewski MK, Atkinson JP, Oldstone MBA. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc Natl Acad Sci USA 1994;91:2161-2165.
27. [27] Iwata K, Seya T, Yanagi Y, Pesando JM, Johnson PM, Okabe M, Ueda S, Ariga H, Nagasawa S. Diversity of the sites for measles virus infection and for inactivation of complement C3b and C4b on membrane cofactor protein (MCP, CD46). J Biol Chem 1995;270:15148-15152.
28. [28] Manchester M, Valsamakis A, Kaufman R, Liszewski MK, Alvarez J, Atkinson JP, Lublin DM, Oldstone MBA. Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). Proc Natl Acad Sci USA 1995;92:2303-2307.
29. [29] Matsumoto M, Seya T, Nagasawa S. Polymorphism and proteolytic fragments of granulocyte membrane cofactor protein (MCP, CD46) of complement. Biochem J 1992;281:493-499.
30. [30] Seya T, Ballard L, Bora N, Kumar V, Cui W, Atkinson JP. Distribution of membrane cofactor protein (MCP) of complement in human peripheral blood cells. Eur J Immunol 1988;18:1289-1294.
31. [31] Kurita M, Yanagi Y, Hara T, Matsumoto M, Ueda S, Seya T. Human lymphocytes are more susceptible to measles virus than granulocytes, which is attributable to the phenotypic differences of their membrane cofactor protein (CD46). Immunol Lett 1995;48:91-95.
32. [32] Gerlier D, Varior-Krishnan G, Devaux P. CD46-mediated measles virus entry: a first key to host range specificity. Trends Microbiol 1995;3:338-345.
33. [33] Fearon DT. The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes. Curr Opin Immunol 1993;5:341-348.
34. [34] Liszewski MK, Tedja I, Atkinson JP. Membrane cofactor protein (CD46) of complement. Processing differences related to alternatively spliced cytoplasmic domains. J Biol Chem 1994;269:10776-10779.
35. [35] Hirano A, Yant S, Iwata K, Korte-Sarfarty J, Seya T, Nagasawa S, Wong TC. Cellular receptor CD46 is down-regulated through recognition of its transmembrane-cytoplasmic domains rather than hemagglutinin-binding domain in cells persistently infected by measles virus. 1996 J Virol (in press).
36. [36] Dierich MP, Ebenbichler CF, Marschang P, Fust G, Thielens NM, Arlaud GJ. HIV and human complement: mechanisms of interaction and biological implication. Immunol Today 1993;14:435-440.
37. [37] Thompson CB. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 1995;81:979-982.
38. [38] Janeway Jr CA, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994;76:275-285.